A tri-block nanoparticle (TBN) comprising of the enzymatically cleavable porous gelatin nanocore encapsulated with gefitinib (tyrosine kinase inhibitor (TKI)) and surface area functionalized with cetuximab-siRNA conjugate continues to be synthesized. the nanoparticle demonstrated minimal toxicity recommending that this cells adjust a parallel GAB1 mediated success pathway. In H23 cells, triggered ERK leads to phosphorylation of… Continue reading A tri-block nanoparticle (TBN) comprising of the enzymatically cleavable porous gelatin